Can a pneumonia shot protect vulnerable myeloma patients?
NCT ID NCT07154537
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study looks at whether the PCV13 pneumonia vaccine is safe and effective for people with multiple myeloma, a blood cancer that raises infection risk. About 100 participants will get either one or two doses of the vaccine. Researchers will check how well the immune system responds and monitor for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Taiwan University Hospital
Taipei, Taipei, 100226, Taiwan
Conditions
Explore the condition pages connected to this study.